T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.
It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...
Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.